High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$7.7M
$7,719,378
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-09 | $704,657 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-06 | $71,572 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-05 | $33,464 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-04 | $54,062 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-03-04 | $49,289 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
2026-03-04
$301,920
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -22.8%
|
2026-03-04 | $301,920 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-03-03 | $315,893x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-03 | $246,910 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-03
$3,690
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-03 | $3,690 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-02-25 | $65,501x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-01-22 | $69,296 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-01-22 | $34,162 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2026-01-15 | $2,685 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-12-22 | $168,492 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-12-15 | $233,548x2 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-25
$103,633x2
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-25 | $103,633x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 SellΔOwn -10.9%
|
2025-11-24 | $330,094 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2025-11-24 | $776,429 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -13.4%
2025-11-24
$101,475
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -13.4%
|
2025-11-24 | $101,475 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-11-21 | $225,588x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-11-21 | $10,981 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-16 | $453,761 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-15 | $226,942x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-15 | $250,391 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-13 | $216,545 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-09 | $116,931 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Raben David
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -38.3%
2025-10-09
$405,900
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -38.3%
|
2025-10-09 | $405,900 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-08 | $102,456 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-07 | $196,844x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 SellΔOwn -11.2%
|
2025-10-07 | $332,386 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
COO
10b5-1 Sell
|
2025-10-06 | $714,998x2 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-06 | $118,356 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Meisner Lara
• Officer • Chief Legal Officer
10b5-1 Sell
2025-09-29
$498,653
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-09-29 | $498,653 | S | Form 4 |
|
BCAX
S
Bicara Therapeutics Inc.
Meisner Lara
• Officer • Chief Legal Officer
10b5-1 Sell
2025-09-15
$181,875
|
||||||
| BCAX |
Bicara Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-09-15 | $181,875 | S | Form 4 |